29 Sep Ciplavasc 5 (Amlodipine besylate 5mg)
| Company name & Address: | Registration number | Batch number | Expiry date | Pack size | First Distribution date | Re-call
Classification |
Recall date |
| Cipla Medpro (Pty) Ltd.
Building 2 Junxion Park 10 Elephant Lane Century City South Africa 7441 |
A 39/7.1/0117 |
ZA260565 |
May 2029
|
30’s |
22 July 2026 |
Class I Type B |
25 September 2026 |
Brief description of the problem (reason for recall)
Cipla Medpro (Pty) Ltd., in collaboration with the South African Health Products Regulatory Authority (SAHPRA), is recalling the following batch of Ciplavasc Tablets Batch Number ZA260565 (SAHPRA allocated registration number: A 39/7.1/0117). This recall has been initiated following packaging-related complaints, where some Ciplavasc 5 mg blister strips were packed into cartons labelled as Ciplavasc 10 mg.
Advice for health professionals and distributors:
We request that you refrain from selling or dispensing any pack of the affected batch of Ciplavasc Tablets ZA260565; and return them to your supplying warehouse or distributor with immediate effect.
Cipla Medpro (Pty) Ltd. will arrange for your stock to be credited / replaced. For further product information, please call Cipla Medpro (Pty) Ltd. via our Customer Care line (080 222 6662).
We thank you in advance for your co-operation and apologise for any inconvenience caused.
Proposed action taken and its urgency: A SAHPRA-approved recall letter was distributed to all distribution points, and the recall process was initiated.
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.